コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 cognitive control (i.e., stimulus preceding negativity).
2 tients who are defined as having imaging MRD negativity.
3 cal to the primary diagnosis except for CD19 negativity.
4 responded achieved minimal residual disease negativity.
5 d potentials (LF-ERPs), such as the mismatch negativity.
6 d blood-culture positivity, or blood-culture negativity.
7 All cases showed p53 immuno-negativity.
8 itive as collaterally determined by mRNA ISH negativity.
9 34 patients (76%, 95% CI 62-89) achieved PET-negativity.
10 sion-free survival in patients achieving MRD negativity.
11 l Cox regression to analyse time to antibody negativity.
12 derived that determined nodal positivity or negativity.
13 ous other community preferences unrelated to negativity.
14 rrant full-thickness CK17 positivity and CK7 negativity.
15 ca because of the protective effect of Duffy negativity.
16 y normal controls used as a standard for tau negativity.
17 icity, 6.6% false positivity, and 4.8% false negativity.
18 , potentially reflecting adaptation to Duffy negativity.
19 e N200, P300/N400, and phonological mismatch negativity.
20 investigate potential reasons for PET false negativity.
21 4%) of 542 achieved minimal residual disease-negativity (10(-5) sensitivity threshold, assessed by mu
22 0177), as did minimal residual disease (MRD) negativity (10-5 threshold) rates in the intent-to-treat
23 day 5 viral RNA (44.7% vs 40.2%) or culture negativity (100.0% vs 98.1%), RNA decline rate, and dura
24 ependent predictive factor affecting HCV RNA negativity 6 months after liver transplantation (OR:11.2
26 ssion-free survival (45%) compared with PET2 negativity (81%, P < 0.002), DeltaSUVmax (>71 vs </=71%)
28 rning from mistakes (i.e., the error-related negativity), a putative index of prediction error signal
30 ion between hexokinase-2 expression and this negativity: a finding which may also be relevant for cli
31 ion as reflected by reduced feedback-related negativity (ADHD, 0.61 [3.90] muV; controls, -1.68 [2.52
33 asured the amplitude of the feedback-related negativity, an event-related brain potential associated
34 characterized by an early (200 ms) posterior negativity and a later (>300 ms) parietal positivity in
35 st-person perspective enhanced error-related negativity and medial-frontal theta power in the trials
37 ing (N2) and error processing (error-related negativity and positivity) from an arrow flanker task wi
38 osed sialic acids reduces macrophage surface negativity and severely impairs directional migration of
40 is associated with the magnitude of mismatch negativity and, critically, is impaired in healthy peopl
41 67 >20%, age <=35 years, or hormone receptor negativity), and randomly assigned them to adjuvant anth
42 Group performance status of 2 or lower, HIV negativity, and absence of comorbidity disallowing proto
44 rs, reaction time variability, error-related negativity, and error-related positivity (all p </= .05)
45 an epidermal growth factor receptor 2 (HER2) negativity, and histologic grade 1 in luminal A tumors.
47 refractory Hodgkin's lymphoma achieving PET-negativity, and therefore could optimise the chance of c
48 ssayed by 3,3'-dihexyloxacarbocyanine iodine negativity, annexin positivity, and poly (adenosine 5'-d
49 bsequent ERP component, the visual awareness negativity ( approximately 260-300 ms), were absent duri
50 mong the measures studied, P300 and mismatch negativity are notable because deficits predict conversi
51 ly those classically termed feedback-related negativity, are modulated by both the reward level and s
53 olecular features, such as estrogen receptor negativity as well as HER2-enriched and basal-like PAM50
54 ation between electromechanical window (EMW) negativity, as derived from echocardiography, and sympto
58 and impact on minimal residual disease (MRD) negativity because this end point has been associated wi
59 stent with the previously reported increased negativity bias after insufficient sleep.The Stockholm s
61 nditional nature of the relationship between negativity bias and ideology by arguing that the politic
67 ess reactivity is associated with a stronger negativity bias during ambiguous affective decision-maki
69 group psychology more generally; we observed negativity bias for estimation of out-group, anonymized-
74 hat the difference across individuals in the negativity bias is a key factor in determining political
77 logy by arguing that the political impact of negativity bias should vary as a function of (1) issue d
78 san meta-perceptions are subject to a strong negativity bias with Democrats and Republicans agreeing
80 riers in three behavioral domains, that is, 'negativity bias' (negative valence), 'apathy' (arousal)
81 ferences points not to global differences in negativity bias, but to differences in threat bias, prob
88 our results make clear the pervasiveness of negativity biases on average, they help account for the
89 omprehensive cross-national demonstration of negativity biases to date, but they also serve to highli
94 itivity was associated with hormone receptor negativity (chi(2) P < .001) and nodal positivity (chi(2
95 those who achieved CSF cryptococcal culture negativity compared to those with positive cultures pre-
96 y enhanced error-related and correct-related negativity compared with healthy comparison subjects.
97 ude of the sustained posterior contralateral negativity component (SPCN, 300-400 ms) decreased, indic
98 propose a framework based on alternating non-negativity-constrained least squares which accounts for
104 oencephalographic recordings of the mismatch negativity elicited in a large cohort of human subjects,
106 mans have established larger early posterior negativity (EPN) in response to pictures depicting snake
107 with the P2 and encompassing early posterior negativity (EPN), P3, and the late positive potential (L
108 to motivational salience-the Early Posterior Negativity (EPN), reflecting earlier selective attention
110 ssing and coupling between the error-related negativity (ERN) and consecutive behavioural slowing.
111 nce monitoring, indexed by the error-related negativity (ERN) and manifested by performance adaptatio
113 monitoring, as measured by the error-related negativity (ERN) in the event-related potential, is a re
115 areness studies found that the error-related negativity (ERN), an event-related potential (ERP) origi
116 rmance monitoring, such as the Error-Related Negativity (ERN), are considerably influenced by situati
117 monitoring, as measured by the error-related negativity (ERN), is a transdiagnostic neurobiological m
118 lus-locked P2, response-locked error-related negativity (ERN/Ne), and response-locked error positivit
119 etection (the latter indexed by the mismatch negativity event-related potential) relies on probabilit
120 12 months of ibrutinib plus venetoclax, MRD negativity (fewer than one CLL cell in 10,000 leukocytes
122 we studied as a measure of RPE the feedback negativity (FN) that is sensitive to both reward and the
123 vent-related potential, the feedback-related negativity (FN), is evoked over the ACC whenever expecta
125 n overt PMF (7.2 vs 17.6 years), with triple negativity for driver mutations and presence of HMR muta
128 and a neural modulation of feedback-related negativity (FRN) and stimulus-preceding negativity (SPN)
129 justment: the frontocentral feedback-related negativity (FRN) and two P300 (P3) subcomponents, the fr
131 data demonstrated a larger feedback-related negativity (FRN) in response to money loss during risk t
134 contingencies modulated the Feedback-Related Negativity (FRN), a human brain potential known to index
135 ents, including the P2, the feedback-related negativity (FRN), and the late positive component (LPC),
136 eration of this ERP and the feedback-related negativity (FRN), often assumed to reflect reward-predic
137 ll studied in humans is the feedback-related negativity (FRN), which is assumed to indicate activatio
138 N1), motivational salience (feedback-related negativities [FRN]), and cognitive appraisal (P300) stag
139 29), automatic auditory processing (mismatch negativity), g = -0.44, 95% CI (-0.66, -0.22), and perfo
142 ency response (P < 0.05); and (iii) mismatch negativity generation to trained versus untrained tones
143 Multivariate analysis identified that HPV negativity (hazard ratio [HR], 2.9; 95% CI, 2.0 to 5.0),
144 tor receptor 2 positivity, estrogen receptor negativity, high tumor grade, and large tumor size.
146 teractions and is unambiguously indicated by negativities in the phase-space quasi-probability distri
147 Conclusion: Beyond HK2 expression, (18)F-FDG negativity in (mainly pretreated) MM patients seems to b
149 was to describe the proportion of PET false-negativity in a representative set of 227 newly diagnose
150 log10 reduction >= 3 and achievement of MRD negativity in BM and PB were significantly associated wi
151 The hazard ratios for the time to culture negativity in both solid and liquid mediums for the ison
153 tolerable and demonstrates high rates of MRD negativity in NDMM, translating into longer progression-
154 compared to controls, with more profound EMW negativity in patients with symptomatic LQTS compared to
157 ivity in hERG K(+) channel blockage testing, negativity in the Ames test, and 5/5 cure @ <15 mpk x 3
159 monitoring, as measured by the error-related negativity in the event-related brain potential, represe
160 es elicited a larger frontocentral sustained negativity in the evoked potential as well as enhanced p
163 sing was associated with the visual mismatch negativity independently of consciousness and task relev
165 The EFS hazard ratio (HR) for achieving MRD negativity is 0.23 (95% Bayesian credible interval [BCI]
167 opped until clinical recovery and SARS-CoV-2 negativity is established and treatment with biologicals
168 lantation (18)F-fluorodeoxyglucose (FDG) PET-negativity is one of the strongest predictors of outcome
171 ndex of cognitive control, the error-related negativity, is investigated to examine its suitability a
176 d that the amplitude of the feedback-related negativity, measured as the difference wave in the event
177 ion between functional outcomes and mismatch negativity (MMN) activity in participants with mood diso
178 nt-related potential studies as the mismatch negativity (MMN) and has been observed in several sensor
179 in, the focus is on sensory gating, mismatch negativity (MMN) and P300, thereby discussing which para
183 ed event-related potential known as mismatch negativity (MMN) and provides a potential link between n
185 icits in the generation of auditory mismatch negativity (MMN) generation are among the most widely re
186 processing: prepulse inhibition and mismatch negativity (MMN) in SZ patients and healthy subjects (HS
196 rison subjects (NCSs) who underwent mismatch negativity (MMN) testing via their participation in the
198 was conducted to determine whether mismatch negativity (MMN), an event-related potential index of au
200 had developed PTSD showed enhanced mismatch negativity (MMN), increased theta power (5-7 Hz), and st
201 signatures of neurodynamics, namely mismatch negativity (MMN), P300, and contingent negative variatio
202 paradigms were presented to derive mismatch negativity (MMN), which reflects the ability to automati
207 uptions on auditory discrimination (mismatch negativity; MMN) responses to phoneme and tone changes i
208 ars; n = 23) showed age-appropriate mismatch negativities (MMNs) to sounds, but older children (12-16
210 of MFC activity on errors, the error-related negativity (Ne/ERN), in a task in which two types of err
212 We show that this improvement stems from the negativity of a particular quasiprobability distribution
216 f OA and WEA was based on the positivity and negativity of results on specific inhalation challenges,
220 s because they (1) are uncorrelated with the negativity of the stimuli being considered, (2) do not r
224 ency (p = .644), Infrequency (p = .097), and Negativity (p = .456) were not statistically significant
225 emphasis and found that the feedback-related negativity, P300, and late positive potential could coll
228 s of processing: the posterior contralateral negativity (PCN) was used to index focal-attentional sel
230 le, that controls tuberculin skin test (TST) negativity per se, that is, T-cell-independent resistanc
231 f the HR hybrid method itself, and sometimes negativity phenomena may even improve the accuracy.
232 iological signatures: an early left anterior negativity post code switch onset - a LAN - followed by
233 50.7% of patients with IGHV-M achieved MRD-negativity posttreatment; of these, PFS was 79.8% at 12.
234 stimulation eliciting the cortical mismatch negativity potential demonstrate deficits in early senso
235 w effect), as well as a sustained widespread negativity, potentially indicative of memory searches fo
237 iveness such as high grade, hormone receptor negativity, presence of a basal-like or TNBC phenotype a
242 demonstrated superior circumferential margin negativity rates with LP compared with OP (odds ratio 1.
243 intracortical homolog of the "object-related negativity" recorded noninvasively in humans, which corr
244 trate the long-term benefit of achieving MRD negativity, regardless of the therapeutic setting and tr
247 ing with their full-thickness positivity and negativity, respectively, in normal conjunctival epithel
249 d index of auditory perception, the mismatch negativity response, tested whether the therapies altere
250 oral networks, including an evoked 'mismatch negativity' response and transiently induced oscillation
253 , while bipolar probands scored higher on a "negativity" scale compared with their co-twins and contr
257 elated potentials, such as the error-related negativity.SIGNIFICANCE STATEMENT A minimal model of lay
259 erceptual training improved the EEG mismatch negativity significantly more than executive training im
260 uted multivoxel pattern reflecting affective negativity) simulated the presumed affective state of th
261 ated negativity (FRN) and stimulus-preceding negativity (SPN) following outcome value modulation.
263 l response shares similarities with mismatch negativity, suggesting the involvement of anterior cingu
264 atial and temporal features as error-related negativity, the electrophysiological correlate of perfor
265 nclude task-based fMRI (RISE task), mismatch negativity, the Scale for the Assessment of Negative Sym
268 obesity was associated with weaker implicit negativity toward overweight people compared to thin peo
269 besity was associated with stronger implicit negativity toward overweight people compared to thin peo
270 f personal obesity is associated with weaker negativity toward overweight people on both explicit (i.
271 people consistently overestimated out-group negativity towards the collective behaviour of their in-
272 ess by which early individual differences in negativity unfold and are shaped by both genes and envir
273 automated method, amyloid-beta positivity or negativity using a standardised uptake value ratio appro
274 The rate of minimal residual disease (MRD) negativity using modified ITT was 70% according to next-
275 genetics, with prognostic superiority of MRD negativity versus CR particularly evident in patients wi
276 uthors connect conservatism with aversion to negativity via the tendentious use of the language of th
277 erse-transcription polymerase chain reaction negativity was 46.4 days after symptom onset (95% confid
278 th resistant virus, the median time to virus negativity was 5.5 days in pocapavir recipients, compare
282 in the word-matching task, while a parietal negativity was elicited by semantically unrelated primes
283 eving at least a near-complete response, MRD negativity was found in 28 of 28 (100% [95% CI, 88%-100%
286 omplete remission (CR) in the absence of MRD negativity was not associated with prolonged progression
290 f valence bias, is associated with increased negativity, we tested how individual differences in acut
293 ral evoked response similar to error-related negativity, which has in turn been implicated in general
297 cent studies suggest that achievement of MRD-negativity with blinatumomab improves outcomes in patien
298 y ClonoSeq achieved minimal residual disease negativity with CLL <1/10 000 white blood cells, which p
299 CHB patients with HVL can achieve HBV DNA negativity with long-term TDF treatment, although time t
300 ponse categories of minimal residual disease negativity, with or without imaging-based absence of ext